Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Cancer immunotherapies should be developed in Vienna

Cancer © Photo: APA (Hochmuth)

"Boehringer Ingelheim invests about EUR 200 million each year in non-clinical and clinical research“, said Philipp von Lattorff, CEO of the regional center for the German pharmaceutical giant in Vienna, which is responsible for 33 countries. He was speaking at a press conference to commemorate the opening of the new research building, built at a cost of about EUR 19 million. It offers space for 80 employees working in the field of immunology.  

The search for new immunotherapeutics to combat cancer is to be intensified in Vienna. According to Darryl McConnell, who heads the research facility in Vienna, the underlying mission following the attack on the “Achilles heel” of tumor cells based on target-oriented therapies is to take away the “caps of invisibility” of these malignant cells, which protect them against the body’s own immune system.

The first such therapies with monoclonal antibodies (checkpoint inhibitors) are already allowed in the case of advanced melanoma and some types of lung cancer. Long-term efficiency only exists at present with about 20 percent of the patients and can thus be significantly improved, for example by means of new, small-sized synthetic active-ingredient molecules, therapeutic monoclonal antibodies and/or anti-cancer vaccines.

The Boehringer-Ingelheim Group has bundled its cancer research in Vienna since the year 2000. Moreover, an additional EUR 20 million is made available to provide basic financing for the Institute for Molecular Pathology (IMP). The new, recently constructed faculty building at IMP cost approximately EUR 50 million.  

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us in St. Petersburg

    24. - 25.05.2018, Санкт-Петербурге

  • Meet us @ Pioneers '18

    24. - 25.05.2018, Vienna

Austria Map

Find the perfect location for your company

Inspite of higher labor costs, the productivity of Siemens Villach is comparable to other Siemens susidiaries in Japan or the USA.

Siemens Austria

Logo
More testimonials

news from the business location Austria

In May Austria is THE startup hotspot

In their role as speakers, Apple co-founder Steve Wozniak, Angie Jones of Twitter and Microsoft AI expert Joseph Sirosh inspired an audience of 8,000 people attending the WeAreDevelopers Conference in Vienna in the middle of May.

Autonomous Driving: Pole Position for Austria

I am a passionate driver, and always have been. As a young person I could hardly wait to finally get my driving license. At the same time, the technology buff in me is looking with great excitement at the revolution currently taking place in the automobile industry. In which direction is this transformation taking the automotive sector? How is our understanding of mobility changing? Are we going to be sitting at the wheel in the future to control the vehicles? Many of the responses to these key questions are coming from Austrian players.

More news All blog posts